Protein Sequence Analysis
Gunalan Vithiagaran, Kenanov Dimitar
Senior Post Doc Reseach Fellows
Post Doc Research Fellow
Lee Tze Chuen
Senior Research Officer
Chong Cheng Shoong Ken, Han Xiaochuan Alvin
Our group's expertise is in computational protein sequence and structure analysis to predict various aspects of molecular and cellular functions (enzymatic activities, posttranslational modifications, cleavage, translocation signals, 3D structures, effects of mutations, phylogenetic relationships, cellular pathways etc.) for discovering the molecular mechanisms of biological and clinical phenotypes and experimental validation together with collaborators. Our repertoire of computational analysis methods is applicable and useful in multiple research areas but our main focus currently is on infectious diseases, human mutations, allergy and enzyme function prediction.
One of our traditional strongholds since the swine flu in 2009 is infectious disease research. Our FluSurver (http://flusurver.bii.a-star.edu.sg/) is the most complete one-stop influenza mutation analysis tool being used by researchers and surveillance experts globally. We have several published and ongoing projects with the WHO CC in Australia and National Influenza Centres relating to influenza drug resistance, viral fitness, host specificity and antigenic changes. The FluSurver is also a primary analysis tool for GISAID, the most complete influenza database also known for always hosting the latest outbreak sequences.
Because we can quickly go from genomes to protein structures through modelling in our computers often only requiring the new sequences as input, our group offers powerful support in infectious disease surveillance and rapid outbreak investigations to get a quick handle on bugs here and around the world. Besides Influenza, we also helped characterizing MERS, Ebola, HIV, Noro, Adeno, Hepatitis C, West Nile, Dengue and Zika viruses. Through close collaboration with the National Public Health Laboratory at the National Centre for Infectious Diseases of the Ministry of Health we contribute our knowledge and computational expertise at the national frontline for infectious disease surveillance.
Human Mutations and Protein Sequence Analysis
We aim at bridging the gap from nucleotide variation to protein structures to interpret effects of human mutations. For example, we have helped clinical collaborators to analyze variants found in patients and tried to mechanistically explain their possible role in a range of diseases like cancer, myopia, leprosy or atopic dermatitis. We are participating in the National Precision Medicine Programme to help mapping mutations into 3D protein structures relative to drug binding sites.
In our ongoing flagship industry project, large multinational Procter & Gamble and BII are jointly developing animal-testing-free Bioinformatics techniques for assessing the allergy potential of proteins using their amino acid sequence and tertiary structure. Often including industry collaborations, we are applying our sequence function and pathway analysis capabilities to support BII’s Natural Product Library and the A*STAR Biotransformation Innovation Platform as well as the Pharma Innovation Programme Singapore. A new direction is to support A*STAR’s Innovations in Food and Chemical Safety programme at the academia-industry interface. In this collaboration with many different groups, our role includes in silico protein allergy prediction, protein binding target identification, pathway analysis and to highlight common SNPs in the local population that may alter the response to toxic compounds.
Protein Sequence Analysis Group Members
Dr. MAURER-STROH Sebastian
Senior Principal Investigator
|Dr. MAURER-STROH Sebastian||Principal Investigator|
|Dr. LIMVIPHUVADH Vachiranee||Research Scientist|
|Dr. TAN Soon Heng, Chris||Postdoctoral Fellow|
|Dr. VITHIAGARAN Gunalan||Postdoctoral Fellow|
|Dr. KENANOV Dimitar||Postdoctoral Fellow|
|Dr. NISKA Joanna||Postdoctoral Fellow|
|Mr. LEE Tze Chuen||Research Officer|
|Mr. HAN Xiaochuan Alvin||PhD student|
|Mr. CHONG Cheng Shoong, Ken||PhD student|
This section is still work in progress.